Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Catalent

Catalent

Rank: 44

Somerset, N.J., USA
www.catalent.com

2020 Revenues ($USD) : $3,094,300,000
2020 R&D spend : $63,800,000
2020 Number of Employees : 15,000
Fiscal Year End : 6/30/2020
Key People : John Chiminski, CEO

The Somerset, N.J.–headquartered company was formed in 2007 when the investment management company the Blackstone Group purchased the pharma technologies and services division of Cardinal Health. Catalent now specializes in drug delivery, biologics, drug manufacturing and gene therapies. In February 2020, it acquired Masthercell Global, a contract developer of cell and gene therapy. The company had a solid financial footing in 2020, delivering record financial results in its fiscal year that ended on June 30. Catalent became a public company in 2014 and joined the S&P 500 index on Sept. 21, 2020. –BB

Catalent facility

A Catalent facility in Madison, Wis.

Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE